Keep up to date with the latest technological developments happening across the Pharmaceutical industry. Our press releases can help you boost your online reach and exposure worldwide. Our Press releases provides information on the latest research in pharma.
Terumo Blood and Cell Technologies today launches the Advanced Therapy Manufacturing and Innovation ATMI Grant for the Asia Pacific region The ATMI Grant aims to accelerate advanced cell therapy manufacturing and development with an award of up to...
Pfizer Inc announced today that the United States US Food and Drug Administration FDA approved XELJANZ tofacitinib for the treatment of children and adolescents years and older with active polyarticular course juvenile idiopathic arthritis pcJIA Two...
Boehringer Ingelheim and Fraunhofer Institute for Molecular Biology and Applied Ecology IME announce their newly formed collaboration that aims to provide novel microbialbased natural products for development of next generation animal health products...
Applied BioMath wwwappliedbiomathcom the industryleader in applying systems pharmacology and mechanistic modeling simulation and analysis to derisk drug research and development today announced a collaboration with Cullinan Oncology
Jellagen Limited a marine biotechnology company producing highvalue collagen derived from jellyfish has entered into a licensing agreement to grant exclusive patent rights for the development to the Mayo Clinic treatment of vocal cord paralysis
CSL Behring a global biotherapeutics leader announced today that the US Food and Drug Administration FDA has approved an expanded indication for HAEGARDA C Esterase Inhibitor Subcutaneous Human for routine prophylaxis to prevent hereditary angioedema...
Quotient Limitedheadquartered in Eysins Switzerland today announced that on September the US Food and Drug Administration FDA issued an Emergency Use Authorization EUA for Quotients COVID antibody test The test detects antibodies generated in human...
AbbVie today announced that the US Food and Drug Administration FDA has granted Orphan Drug and Fast Track designations for elezanumab ABT an investigational treatment for patients following spinal cord injuryElezanumab is a monoclonal antibody of th...
Sanofi announced today the successful completion of its acquisition of Principia Biopharma Inc Principia for per share in cashThe Principia acquisition further strengthens our core areas of autoimmune and allergic diseases giving us full control of...
Pfizer Inc announced today that the United States US Food and Drug Administration FDA approved XELJANZ tofacitinib for the treatment of children and adolescents years and older with active polyarticular course juvenile idiopathic arthritis pcJIA Two...
